MGMT and non-Hodgkin lymphoma: Temozolomide with good CNS penetration and low toxicity is an oral alkylating agent that affects O6-methylguanine-DNA-methyltransferase (MGMT) status, which are also proved to be effective against non-Hodgkin’s lymphoma [9, 10].